US Bancorp’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-175
| Closed | -$5K | – | 4336 |
|
|
2022
Q1 | $5K | Hold |
175
| – | – | ﹤0.01% | 3646 |
|
|
2021
Q4 | $5K | Sell |
175
-169
| -49% | -$4.58K | ﹤0.01% | 3689 |
|
|
2021
Q3 | $9K | Buy |
344
+169
| +97% | +$4.18K | ﹤0.01% | 3506 |
|
|
2021
Q2 | $3K | Sell |
175
-572
| -77% | -$10.7K | ﹤0.01% | 3783 |
|
|
2021
Q1 | $16K | Hold |
747
| – | – | ﹤0.01% | 3135 |
|
|
2020
Q4 | $17K | Hold |
747
| – | – | ﹤0.01% | 2995 |
|
|
2020
Q3 | $12K | Hold |
747
| – | – | ﹤0.01% | 3035 |
|
|
2020
Q2 | $10K | Buy |
747
+254
| +52% | +$2.96K | ﹤0.01% | 3115 |
|
|
2020
Q1 | $6K | Hold |
493
| – | – | ﹤0.01% | 3222 |
|
|
2019
Q4 | $12K | Hold |
493
| – | – | ﹤0.01% | 3057 |
|
|
2019
Q3 | $8K | Buy |
493
+318
| +182% | +$5.79K | ﹤0.01% | 3139 |
|
|
2019
Q2 | $4K | Sell |
175
-511
| -74% | -$13.8K | ﹤0.01% | 3344 |
|
|
2019
Q1 | $22K | Buy |
686
+37
| +6% | +$1.15K | ﹤0.01% | 2828 |
|
|
2018
Q4 | $18K | Buy |
649
+8
| +1% | +$234 | ﹤0.01% | 2860 |
|
|
2018
Q3 | $19K | Hold |
641
| – | – | ﹤0.01% | 2947 |
|
|
2018
Q2 | $24K | Sell |
641
-90
| -12% | -$3.53K | ﹤0.01% | 2879 |
|
|
2018
Q1 | $29K | Buy |
731
+26
| +4% | +$950 | ﹤0.01% | 2834 |
|
|
2017
Q4 | $23K | Sell |
705
-780
| -53% | -$23.4K | ﹤0.01% | 2892 |
|
|
2017
Q3 | $46K | Buy |
1,485
+560
| +61% | +$16.6K | ﹤0.01% | 2607 |
|
|
2017
Q2 | $26K | Sell |
925
-655
| -41% | -$14.8K | ﹤0.01% | 2808 |
|
|
2017
Q1 | $27K | Hold |
1,580
| – | – | ﹤0.01% | 2754 |
|
|
2016
Q4 | $19K | Buy |
1,580
+790
| +100% | +$10.2K | ﹤0.01% | 2859 |
|
|
2016
Q3 | $13K | Hold |
790
| – | – | ﹤0.01% | 2945 |
|
|
2016
Q2 | $10K | Hold |
790
| – | – | ﹤0.01% | 3010 |
|
|
2016
Q1 | $15K | Hold |
790
| – | – | ﹤0.01% | 2878 |
|
|
2015
Q4 | $18K | Sell |
790
-3,920
| -83% | -$77.5K | ﹤0.01% | 2872 |
|
|
2015
Q3 | $110K | Sell |
4,710
-55
| -1% | -$1.52K | ﹤0.01% | 2029 |
|
|
2015
Q2 | $136K | Buy |
4,765
+4,435
| +1,344% | +$116K | ﹤0.01% | 1959 |
|
|
2015
Q1 | $9K | Buy |
+330
| New | +$7.55K | ﹤0.01% | 3160 |
|
US Bancorp's XENT Position: Q2 2022 in Review
US Bancorp sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 175 shares — an estimated $5K sold.
US Bancorp first reported a position in XENT in Q1 2015 and held it in 29 quarters. The position peaked at $136K in Q2 2015. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- US Bancorp reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- US Bancorp sold 175 Intersect ENT, Inc shares in Q2 2022, an estimated $5K.
- US Bancorp first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 29 quarters.
- US Bancorp's Intersect ENT, Inc position peaked at $136K in Q2 2015.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on US Bancorp's 13F filing for Q2 2022, filed 1 Aug 2022.